Middle East & Africa Radioactive Tracer Market Forecast to 2030

According to the research team’ research,, the Middle East & Africa radioactive tracer market was valued at US$ 268.57 million in 2022 and is expected to reach US$ 602.69 million by 2030, registering a CAGR of 10.6% from 2022 to 2030. Rising prevalence of chronic diseases and increasing use of nuclear imaging techniques are the critical factors attributed to the Middle East & Africa radioactive tracer market expansion.

One of the primary opportunities within the radioactive trace market in Europe lies in the healthcare and diagnostics sector. The emerging economies of region such as Hungary, Poland, and Romania, are experiencing high growth and development in their healthcare infrastructure. The region’s vast and rapidly growing population, coupled with and increasing focus on healthcare infrastructure development, makes it a fertile ground for the application of radioactive tracers. According to CABI estimates, cancer is currently one of the leading causes of mortality in the Middle East and North Africa (MENA). Still, the burden of new cases in the region is expected to nearly quadruple by 2030. Additionally, cardiovascular disease is the foremost cause of mortality in the MENA region, accounting for more than one-third of all fatalities, or 1.4 million people per year, according to the World Heart Federation. Furthermore, a notable increase trend in the point prevalence of Parkinson’s condition has been documented in MENA during the previous three decades, indicating that the condition will continue to be a growing challenge for public health. Radioactive tracers play a significant role in diagnostic imaging techniques such as Positron Emission Tomography (PET) and single Phonton Emission Computed Tomography (SPECT).

As African countries advance their healthcare systems, there is rising demand for precise and early disease detection. Radioactive tracers, which allow for the visualization of molecular and cellular processes within the body, are instrumental in detecting various medical conditions, including cancer, cardiovascular diseases, and neurological disorders. They offer the advantage of early diagnosis and staging, leading to more effective treatment and improved patient outcomes.

Moreover, the increasing awareness among both healthcare professionals and the general public about the benefits of nuclear medicine and molecular imaging is driving the demand for radioactive tracers. This trend is further supported by a growing middle-class population with greater access to healthcare services. Thus, the radioactive tracer market in “region’s name” is poised to experience substantial growth as it becomes an integral component of advanced medical diagnostics and patient care.

On the contrary, short shelf-life of radioactive tracer hurdles the growth of Middle East & Africa radioactive tracer market.

Based on tracer type, the Middle East & Africa radioactive tracer market is categorized into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held 61.1% market share in 2022, amassing US$ 164.19 million. It is projected to garner US$ 347.46 million by 2030 to expand at 9.8% CAGR during 2022–2030.

Based on test type, the Middle East & Africa radioactive tracer market is categorized into PET, SPECT, and others. The SPECT segment held 44.4% share of Middle East & Africa radioactive tracer market in 2022, amassing US$ 119.36 million. It is projected to garner US$ 264.47 million by 2030 to expand at 10.5% CAGR during 2022–2030.

Based on end user, the Middle East & Africa radioactive tracer market is categorized into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held 70.2% share of Middle East & Africa radioactive tracer market in 2022, amassing US$ 188.56 million. It is projected to garner US$ 423.63 million by 2030 to expand at 10.6% CAGR during 2022–2030.

Based on application, the Middle East & Africa radioactive tracer market is categorized into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held 60.6% share of Middle East & Africa radioactive tracer market in 2022, amassing US$ 162.75 million. It is projected to garner US$ 355.08 million by 2030 to expand at 10.2% CAGR during 2022–2030.

Based on country, the Middle East & Africa radioactive tracer market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 34.0% share of Middle East & Africa radioactive tracer market in 2022. It was assessed at US$ 91.18 million in 2022 and is likely to hit US$ 199.79 million by 2030, exhibiting a CAGR of 10.3% during 2022–2030.

Key players operating in the Middle East & Africa radioactive tracer market are Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, General Electric Co, and IBA Radiopharma Solutions, among others.

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Radioactive Tracer Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Rising Prevalence of Chronic Diseases
4.1.2 Increasing Use of Nuclear Imaging Techniques
4.2 Market Restraints
4.2.1 Short Shelf-Life of Radioactive Tracer
4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
4.3 Market Opportunities
4.3.1 Presence of Emerging Economies and Growing Population
4.3.2 Development of Personalized Radiopharmaceuticals for Targeted Therapies
4.4 Future Trends
4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
4.5 Impact Analysis:
5. Radioactive Tracer Market – Middle East & Africa Market Analysis
5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 – 2030
6. Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 – by Tracer Types
6.1 Overview
6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
6.3 Technetium 99m and TC-97m
6.3.1 Overview
6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Iodine 131
6.4.1 Overview
6.4.2 Iodine 131: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Iron 59
6.5.1 Overview
6.5.2 Iron 59: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Lutetium- 171
6.6.1 Overview
6.6.2 Lutetium- 171: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.7 RB82 and ammonia N-13
6.7.1 Overview
6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Scandium 46
6.8.1 Overview
6.8.2 Scandium 46: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Seaborgium-269
6.9.1 Overview
6.9.2 Seaborgium-269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.10 Hassium -269
6.10.1 Overview
6.10.2 Hassium -269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.11 Gallium Citrate GA 67
6.11.1 Overview
6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.12 PSMA GA68
6.12.1 Overview
6.12.2 PSMA GA68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.13 FDDNP (F-18) and FDOPA (f-18)
6.13.1 Overview
6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.14 Phosphorus 32 and Chromium -51
6.14.1 Overview
6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.15 Thallium-201
6.15.1 Overview
6.15.2 Thallium-201: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.16 F-18 FDG
6.16.1 Overview
6.16.2 F-18 FDG: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.17 F-18 FAPI
6.17.1 Overview
6.17.2 F-18 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.18 GA 68 FAPI
6.18.1 Overview
6.18.2 GA 68 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.19 F-18 PSMA
6.19.1 Overview
6.19.2 F-18 PSMA: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
6.20.1 Overview
6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.21 Others
6.21.1 Overview
6.21.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 PET
7.3.1 Overview
7.3.2 PET: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 SPECT
7.4.1 Overview
7.4.2 SPECT: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 – by Application.
8.1 Overview
8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Pulmonary
8.4.1 Overview
8.4.2 Pulmonary: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neurology
8.5.1 Overview
8.5.2 Neurology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Radioactive Tracer Market – Country Analysis
10.1 Middle East & Africa Radioactive Tracer Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 Middle East & Africa Radioactive Tracer Market by Country
10.1.2.1 Saudi Arabia
10.1.2.1.1 Overview
10.1.2.1.2 Saudi Arabia Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1.3 Saudi Arabia Radioactive Tracer Market, by Tracer Types
10.1.2.1.4 Saudi Arabia Radioactive Tracer Market, by Test Type
10.1.2.1.5 Saudi Arabia Radioactive Tracer Market, by Application
10.1.2.1.6 Saudi Arabia Radioactive Tracer Market, by End-User
10.1.2.2 UAE
10.1.2.2.1 Overview
10.1.2.2.2 UAE Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 UAE Radioactive Tracer Market, by Tracer Types
10.1.2.2.4 UAE Radioactive Tracer Market, by Test Type
10.1.2.2.5 UAE Radioactive Tracer Market, by Application
10.1.2.2.6 UAE Radioactive Tracer Market, by End-User
10.1.2.3 South Africa
10.1.2.3.1 Overview
10.1.2.3.2 South Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 South Africa Radioactive Tracer Market, by Tracer Types
10.1.2.3.4 South Africa Radioactive Tracer Market, by Test Type
10.1.2.3.5 South Africa Radioactive Tracer Market, by Application
10.1.2.3.6 South Africa Radioactive Tracer Market, by End-User
10.1.2.4 Rest of Middle East & Africa
10.1.2.4.1 Overview
10.1.2.4.2 Rest of Middle East & Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.3 Rest of Middle East & Africa Radioactive Tracer Market, by Tracer Types
10.1.2.4.4 Rest of Middle East & Africa Radioactive Tracer Market, by Test Type
10.1.2.4.5 Rest of Middle East & Africa Radioactive Tracer Market, by Application
10.1.2.4.6 Rest of Middle East & Africa Radioactive Tracer Market, by End-User
11. Radioactive Tracer Market Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Radioactive Tracer Market, Key Company Profiles
12.1 Rotem Industries Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Invicro LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Cardinal Health Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Newcastle University
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Novartis AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Curium
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 General Electric Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 IBA Radiopharma Solutions
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

Table 1. Middle East & Africa Radioactive Tracer Market Segmentation
Table 2. Principal Radionuclides Used in Radioactive Tracer
Table 3. Saudi Arabia Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Tracer Types
Table 4. Saudi Arabia Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Test Type
Table 5. Saudi Arabia Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 6. Saudi Arabia Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 7. UAE Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Tracer Types
Table 8. UAE Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Test Type
Table 9. UAE Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 10. UAE Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 11. South Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Tracer Types
Table 12. South Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Test Type
Table 13. South Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 14. South Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 15. Rest of Middle East & Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Tracer Types
Table 16. Rest of Middle East & Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Test Type
Table 17. Rest of Middle East & Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 18. Rest of Middle East & Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms, Middle East & Africa Radioactive Tracer Market

Figure 1. Middle East & Africa Radioactive Tracer Market Segmentation, By Country
Figure 2. Middle East & Africa Radioactive Tracer Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Radioactive Tracer Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Middle East & Africa Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
Figure 6. Technetium 99m and TC-97m: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Iodine 131: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Iron 59: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Lutetium- 171: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. RB82 and ammonia N-13: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Scandium 46: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Seaborgium-269: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Hassium -269: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Gallium Citrate GA 67: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. PSMA GA68: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. FDDNP (F-18) and FDOPA (f-18): Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Phosphorus 32 and Chromium -51: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Thallium-201: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. F-18 FDG: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. F-18 FAPI: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. GA 68 FAPI: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. F-18 PSMA: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 26. PET: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. SPECT: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Middle East & Africa Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
Figure 30. Oncology: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pulmonary: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Neurology: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Cardiology: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Others: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Middle East & Africa Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
Figure 36. Hospitals and Clinics: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diagnostic Centers: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Academic and Research Institutes: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. Others: Middle East & Africa Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. Middle East & Africa Radioactive Tracer Market, By Country, 2022 And 2030 ($Mn)
Figure 41. Middle East & Africa Radioactive Tracer Market, By Key Countries, 2022 And 2030 (%)
Figure 42. Saudi Arabia Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. UAE Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. South Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Rest of Middle East & Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)